Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID04870762

A Randomized Study of Head and Neck Radiotherapy With or Without Customized 3D Printed Oral Stents

Led by M.D. Anderson Cancer Center · Updated on 2026-04-15

119

Participants Needed

7

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the effect of customized three-dimensional (3D) printed oral stents in patients with head and neck cancers who are undergoing radiotherapy. The study aims to compare rates of mouth sores, called mucositis, in areas not targeted by radiation between patients who use these oral stents and those who receive standard care. This phase 2 trial also looks at patient-reported experiences, narcotic pain medication use, and imaging and radiation dose differences during treatment. Participants are randomly assigned to one of two groups. One group wears a customized 3D printed oral stent that fits over their teeth and gums during standard radiotherapy, while the other group receives only the standard radiotherapy without the stent. The oral stent is created from a mold of each patient's mouth and is designed to protect oral tissues during treatment. During the study, participants are monitored throughout their radiotherapy course, which lasts 5 to 7 weeks. Researchers collect data on mouth soreness, pain scores, narcotic use, and imaging studies to evaluate radiation effects. These outcomes are tracked for up to one year after treatment to assess the longer-term impact. Participants complete diaries and patient-reported outcome measures to provide detailed information on their symptoms and medication use.

CONDITIONS

Brief Title

Customized 3D Printed Oral Stents During Head and Neck Radiotherapy

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participant is dispositioned to receive 5-7 weeks of definitive or adjuvant radiotherapy for treatment of a diagnosed head and neck malignancy
  • Age 18 or older
  • ECOG Performance Status of 0 to 2
  • Participant will receive radiation alone or radiation with concurrent chemotherapy
  • Signed study-specific consent form
Not Eligible

You will not qualify if you...

  • Prior head and neck radiotherapy
  • Unable to fit a tongue-lateralizing or tongue-depressing stent
  • Severe trismus with an incisal opening of less than 10 mm
  • Inability to comply with study procedures
  • Participants younger than 18 years
  • Participants who are pregnant
  • Cognitively impaired subjects

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Treatment

Duration - 5 to 7 weeks

Participants receive 5 to 7 weeks of head and neck radiotherapy either with a customized 3D printed oral stent or standard of care without the stent.

Radiotherapy visits according to standard care schedule

Follow-up

Duration - Up to 1 year

Participants are monitored for up to 1 year after radiotherapy to evaluate mucositis rates, patient reported outcomes, narcotic use, imaging, and dosimetric differences.

Periodic visits during the follow-up period

Trial Site Locations

Total: 7 locations

1

Banner Health/Banner Research

Phoenix, Arizona, United States, 85234

Actively Recruiting

2

Baptist MD Anderson Cancer Center

Jacksonville, Florida, United States, 32207

Actively Recruiting

3

Community MD Anderson Cancer Center East

Indianapolis, Indiana, United States, 46219

Actively Recruiting

4

Community MD Anderson Cancer Center South

Indianapolis, Indiana, United States, 46227

Actively Recruiting

5

Community MD Anderson Cancer Center North

Indianapolis, Indiana, United States, 46250

Actively Recruiting

6

Cooper Hospital University Medical Center

Camden, New Jersey, United States, 08103

Actively Recruiting

7

M D Anderson Cancer Center

Houston, Texas, United States, 77030

Actively Recruiting

Loading map...

Research Team

A

Anna Lee, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Financial Compass: A Pilot Feasibility Study of a Novel Inte...

Head and Neck Carcinoma

Actively Recruiting

1 location

Radiation De-Escalation Pilot Study for p16-Negative Orophar...

Head and Neck Cancer

Actively Recruiting

6 locations

Accelerator-based Boron Neutron Capture Therapy (BNCT) in th...

Head and Neck Carcinoma

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here